Summary
As the world continues to deal with COVID-19, economies are moving into recession, official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000 at the time of this report. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising.
On a more positive note, we are already seeing signs of recovery as the COVID-19 risk is declining in China. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Intramuscular Injector market in this environment.
In terms of revenue, this research report indicated that the global Intramuscular Injector market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Intramuscular Injector industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Antares Pharma aims at producing XX Intramuscular Injector in 2020, with XX % production to take place in global market, Endo International Plc accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Intramuscular Injector Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Intramuscular Injector Market?
Antares Pharma
Endo International Plc
Bioject Medical Technologies
PharmaJetMedical International Technology
National Medical Products
Valeritas
European Pharma Group
PenJet Corporation
Becton
Dickinson
Injex Pharma AG
Crossject SA
Solace Biotech
Sanify Healthcare Private Limited
Novosanis
Vata
Kaleo
...
Major Type of Intramuscular Injector Covered in XYZResearch report:
Pre-fillable Injection System
Fillable Needle-free Injectors
Application Segments Covered in XYZResearch Market
Hospitals
Clinics
Ambulatory Surgery Centers
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Intramuscular Injector Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Pre-fillable Injection System -Product Introduction and Major Manufacturers
1.1.2 Fillable Needle-free Injectors -Product Introduction and Major Manufacturers
1.1.3 -Product Introduction and Major Manufacturers
1.1.4 -Product Introduction and Major Manufacturers
1.1.5 -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Intramuscular Injector Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Intramuscular Injector Market
3.1.1 Top Companies leading Intramuscular Injector Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Intramuscular Injector Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Intramuscular Injector Market
3.2.1 Top Companies leading Intramuscular Injector Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Intramuscular Injector Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Intramuscular Injector Market
3.3.1 Top Companies leading Intramuscular Injector Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Intramuscular Injector Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Intramuscular Injector Market
3.4.1 Top Companies leading Intramuscular Injector Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Intramuscular Injector Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Intramuscular Injector Market
3.5.1 Top Companies leading Intramuscular Injector Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Intramuscular Injector Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Intramuscular Injector Market
3.6.1 Top Companies leading Intramuscular Injector Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Intramuscular Injector Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Intramuscular Injector Market
3.7.1 Top Companies leading Intramuscular Injector Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Intramuscular Injector Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Intramuscular Injector Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Intramuscular Injector Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Intramuscular Injector Sales and Growth Rate (2021-2026)
5.2 Global Intramuscular Injector Sales Value and Growth Rate (2021-2026)
6 Intramuscular Injector Competitive Analysis
6.1 Antares Pharma
6.1.1 Antares Pharma Company Profile
6.1.2 Antares Pharma Product Introduction
6.1.3 Antares Pharma Intramuscular Injector Business Performance (2015-2020)
6.1.4 SWOT Analysis
6.2 Endo International Plc
6.2.1 Endo International Plc Company Profile
6.2.2 Endo International Plc Product Introduction
6.2.3 Endo International Plc Intramuscular Injector Business Performance (2015-2020)
6.2.4 SWOT Analysis
6.3 Bioject Medical Technologies
6.3.1 Bioject Medical Technologies Company Profile
6.3.2 Bioject Medical Technologies Product Introduction
6.3.3 Bioject Medical Technologies Intramuscular Injector Business Performance (2015-2020)
6.3.4 SWOT Analysis
6.4 PharmaJetMedical International Technology
6.4.1 PharmaJetMedical International Technology Company Profile
6.4.2 PharmaJetMedical International Technology Product Introduction
6.4.3 PharmaJetMedical International Technology Intramuscular Injector Business Performance (2015-2020)
6.4.4 SWOT Analysis
6.5 National Medical Products
6.5.1 National Medical Products Company Profile
6.5.2 National Medical Products Product Introduction
6.5.3 National Medical Products Intramuscular Injector Business Performance (2015-2020)
6.5.4 SWOT Analysis
6.6 Valeritas
6.6.1 Valeritas Company Profile
6.6.2 Valeritas Product Introduction
6.6.3 Valeritas Intramuscular Injector Business Performance (2015-2020)
6.6.4 SWOT Analysis
6.7 European Pharma Group
6.7.1 European Pharma Group Company Profile
6.7.2 European Pharma Group Product Introduction
6.7.3 European Pharma Group Intramuscular Injector Business Performance (2015-2020)
6.7.4 SWOT Analysis
6.8 PenJet Corporation
6.8.1 PenJet Corporation Company Profile
6.8.2 PenJet Corporation Product Introduction
6.8.3 PenJet Corporation Intramuscular Injector Business Performance (2015-2020)
6.8.4 SWOT Analysis
6.9 Becton
6.9.1 Becton Company Profile
6.9.2 Becton Product Introduction
6.9.3 Becton Intramuscular Injector Business Performance (2015-2020)
6.9.4 SWOT Analysis
6.10 Dickinson
6.10.1 Dickinson Company Profile
6.10.2 Dickinson Product Introduction
6.10.3 Dickinson Intramuscular Injector Business Performance (2015-2020)
6.10.4 SWOT Analysis
6.11 Injex Pharma AG
6.12 Crossject SA
6.13 Solace Biotech
6.14 Sanify Healthcare Private Limited
6.15 Novosanis
6.16 Vata
6.17 Kaleo
7 Conclusion
